As drug resistance strictly limits the therapeutic efficacy of chemotherapy and seriously harms patients' health and life, increasing attention has been paid to whether NLRP3 can also regulate the malignant processes against drug resistance in cancer. This evidence concerns the gene NLRP3 and cancer.